Experimental Approach to develop a Novel Bioelastic polymer using the Prion Protein

Home

Prion?

Diseases

 

Prion Biodata

Gene

Diagnostics

Prion Structure

Engineers?

Assay

 

 

·       The Abnormal Prion Protein is

*   Rich in β sheets

*   Protease resistant

*   Detergent insoluble

·       Elastin has VPGG sequence that imparts elasticity to the membrane

HYPOTHESIS

Is it possible to use a polymer of both the elastin peptide and prion protein and generate an elastic biopolymer?

 

 

Chemistry of the Solid Phase Peptide Synthesis

Prusiner et al have been successful in using a highly optimized Fmoc chemical technique involving DCC/HOBt activation and an efficient capping procedure with N-(2-Chlorobenzylooxycarbonyloxyl) succinimide. A single reverse phase purification step gave a high yield of homogenous protein. This method helps to remove all the side – products that accumulate during the various steps.

After synthesis, peptide sequence must be confirmed by Edman’s degradation.

Controls – Use variants of the VPGG sequence by introducing amino acids like Isoleucine.
Construct various mutant versions of prion protein with the inserted VPGG repeats and compare them with the so called wild type polymer that has the full length sequence of the prion protein.

 

Membrane Polymer obtained now has to be subjected to various tests as follows

 

1.      Secondary Structure Determination by CD and FITR

 

2.    Determine Antigenic Nature of the Polymer –

In vivo tests in animals like mice will be the next step to determine if these polymers are antigenic.

3.    Determine Physical Properties of the Membrane

Elasticity may be determined under physiological conditions. Thermal stress will also be used to determine the protein’s elasticity. Atomic force microscopy can also be used to determine the elasticity.

4.    Ability of this Prion Polymer to induce conformational changes in the abnormal Prion Protein

Incubation of the normal cellular Isoform with the polymer and determine by Western Blot and Proteinase K digestion assays.

 

APPLICATIONS

If non-antigenic then this Biopolymer might find applications in medicine for drug delivery, protect important tissues that are damaged, coat foreign articles that might be needed to maintain the integrity of the body’s organs.

 

 

 

 

References:

How Atomic Force Microscopy works

 

Elastic Biomolecular Machines; Scientific American January 1995; by Dan Urry

Engineering the prion protein using chemical synthesis; H.L. Ball, D.S. King, F.E. Cohen, S.B.Prusiner, M.A. Baldwin – J. Peptide Res, 2001, 58, 357 - 374

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Abnormal Prion protein is attached to beads by chemical synthesis.

 

Then VPGG peptide linkers that contain highly reactive functional reactive groups are added that bind to the prion protein (This is similar to blocking and deblocking that are used in peptide synthesis e.g. t-BOC, FMOC)

 

Repeat the process

 

Ultimately a polymer sheet is obtained.

 

 

 

ELATED PageKits © 2002 ELATED.com/PageKits.com